Home › Drug Codes › Q Codes › Q5154 · OMLYCLO
Updated October 1st, 2026

OMLYCLO Q Code: Q5154

Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg

Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
$46.609
/ HCPCS billing unit · APC 0979
ASP ?
No current ASP
Not available for Q4 2026
WAC ?
$44.023
/ HCPCS billing unit
AWP ?
$52.828
/ HCPCS billing unit
NDCs Crosswalked ?
3
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
HCPCS Added Date October 1, 2025
Manufacturer Celltrion USA
Route of Administration Subcutaneous
Generic Status Single-Source; Branded
Dosage Form Injection

About OMLYCLO

Omlyclo is a medication aligned to the HCPCS Q Code: Q5154 for billing, pricing, and reimbursement purposes in the United States. It is an Immunology drug administered via the subcutaneous route and manufactured by Celltrion USA.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Package Manufacturer HCPCS Units WAC AWP
72606-0035-01
75 MG / 0.5 ML Omlyclo Subcutaneous Injection 75 MG/0.5ML - 1 SYRINGE, GLASS in 1 CARTON (72606-035-01) / .5 mL in 1 SYRINGE, GLASS
CELLTRION USA, Inc. 15 $660.35 $44.023 / unit $792.42 $52.828 / unit
72606-0036-01
150 MG / 1 ML Omlyclo Subcutaneous Injection 150 MG/1ML - 1 SYRINGE, GLASS in 1 CARTON (72606-036-01) / 1 mL in 1 SYRINGE, GLASS
CELLTRION USA, Inc. 30 $1,320.70 $44.023 / unit $1,584.84 $52.828 / unit
72606-0054-01
300 MG / 2 ML Omlyclo Subcutaneous Injection 300 MG/2ML - 1 SYRINGE, GLASS in 1 CARTON (72606-054-01) / 2 mL in 1 SYRINGE, GLASS
CELLTRION USA, Inc. 60 $2,641.40 $44.023 / unit $3,169.68 $52.828 / unit

Effective 9/1/26 (WAC & AWP)

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

OMLYCLO Pricing & Reimbursement

Q5154 Private Payer Reimbursement
$410.78 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

HCPCS Units
%
Common:

Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.

Estimated Reimbursement

Omalizumab Biosimilar Information:

OMLYCLO Approval Date: March 7, 2025

Product Name HCPCS Code Active Ingredient BLA Type
Xolair J2357 Omalizumab 351(a) Originator Product
Omlyclo Q5154 Omalizumab 351(k) Interchangeable

OMLYCLO CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

OMLYCLO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Asthma Chronic Rhinosinusitis with Nasal Polyps Chronic Spontaneous Urticaria IgE-Mediated Food Allergy
Drug Class
Anti-IgE [EPC]Decreased IgE Activity [PE]IgE-directed Antibody Interactions [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Omlyclo billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for OMLYCLO.
Are there any available Omlyclo patient assistance programs?
OMLYCLO patient assistance information can be found through Celltrion USA Inc.. Visit Here →
Where can I find Omlyclo prescribing information?
Omlyclo prescribing information can be found through the link below. Visit Here →
Where can I find Omlyclo side effect information?
Omlyclo side effect information can be found at the link below. Visit Here →
Does billing Omlyclo require wastage modifiers?
CMS does not include OMLYCLO (Q5154) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5154. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.